Pricing Log in Create free account

Enanta Pharmaceuticals, Inc. (ENTA) vs Kyverna Therapeutics, Inc. (KYTX)

Enanta Pharmaceuticals, Inc. and Kyverna Therapeutics, Inc. are both Biotechnology companies. Enanta Pharmaceuticals, Inc. and Kyverna Therapeutics, Inc. are of similar size ($293.6M and $285.1M). Kyverna Therapeutics, Inc. has the higher net margin (0.00% vs −96.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Enanta Pharmaceuticals, Inc. leads on 6 and Kyverna Therapeutics, Inc. on 6.

Valuation

Metric ENTA KYTX Biotechnology median
P/E n/m n/m 10.60
P/S 4.90 n/m 9.40
P/B 3.17 1.78 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.00 n/m 9.02
Earnings yield (21.91%) (60.62%) (32.88%)
Free cash flow yield (11.54%) (53.83%) (23.13%)

Profitability

Metric ENTA KYTX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (89.99%) 0.00% 0.00%
Net margin (96.89%) 0.00% 0.00%
Free cash flow margin (56.60%) 0.00% 0.00%
Return on equity (70.12%) (87.24%) (51.96%)
Return on assets (21.15%) (68.40%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENTA KYTX Biotechnology median
Revenue growth (TTM) 0.70% — 6.76%
EPS growth (last fiscal year) 29.93% (9.31%) 29.88%
Revenue growth, 5-year CAGR (11.81%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ENTA KYTX Biotechnology median
Debt to equity 0.00 0.15 0.00
Current ratio 3.76 9.06 4.97
Net debt to EBITDA 2.35 1.51 1.01

Dividend

Metric ENTA KYTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ENTA KYTX Biotechnology median
Market cap 293.59m 285.10m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack